Company news
Bioasis Technologies Inc. news in 2019
Bioasis Technologies Inc.'s news releases, calls and decks from 2019, newest first.
Bioasis Completes Bridge Financing Transaction
December 23, 2019
Bioasis Announces Bridge Financing
December 16, 2019
Bioasis Appoints Consultant Chief Medical Officer and Nominates Medical Oncology Advisory Board
December 4, 2019
Bioasis to Host Annual General Meeting Webcast on December 5, 2019
November 27, 2019
Bioasis Announces Director Resignation
November 25, 2019
Bioasis Announces Issuance of Japanese Patent Relating to xB3™ Platform Technology for The Delivery of Therapeutic Agents Across The Blood-Brain Barrier
November 14, 2019
Bioasis Completes Financing Transactions
November 8, 2019
Bioasis Announces Filing of Its Quarter and Financial Statements and MD&A for the Period Ending August 31, 2019
October 25, 2019
Bioasis Announces Proposed Private Placement
September 23, 2019
Bioasis Announces Allowance of Patent Application in Japan Relating to xB3 Platform Technology for the Delivery of Therapeutic Agents Across the Blood-Brain Barrier
September 11, 2019
Bioasis Announces Registration and Grant Notice of Patent Application in China Relating to xB3 Platform Technology for the Delivery of Therapeutic Agents Across the Blood-Brain Barrier
August 21, 2019
Bioasis Strengthens Senior Management Team with Appointment of Caroline Dircks, Ph.D. as Chief Operating Officer
August 15, 2019
Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending May 31, 2019
July 26, 2019
Bioasis Announces FDA Response to Pre-IND Submission
June 25, 2019
Bioasis Announces Allowances of Patent Applications in the U.S. and Europe Relating to xB3 Platform Technology and Key Therapeutic Indications
June 24, 2019
Bioasis Appoints Mario Saltarelli as Non-Executive Director of the Board of Directors
May 30, 2019
Bioasis Announces Closing of Previously Disclosed Private Placement
May 21, 2019
Bioasis Announces Private Placement
May 6, 2019
Bioasis Technologies Inc. Announces Warrant Extension
March 25, 2019
Bioasis Appoints Dr. Deborah Rathjen as President & Chief Executive Officer
March 11, 2019
Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending November 30, 2018
January 29, 2019
Bioasis Announces the Appointment of Christine Antalik as Chief Financial Officer
January 9, 2019
Bioasis Announces Agreement With Leading Pharmaceutical Company for Pre-Clinical Research Using the xB3 Platform Technology
January 7, 2019
Decks in 2019
- Investor Presentation (September 2019)
Investor deck · 55 slides · September 2019